FDA Clears Mylan Over Ignored Computer Warnings

Law360, New York (August 13, 2009, 6:33 PM EDT) -- The U.S. Food and Drug Administration has concluded an inquiry into Mylan Pharmaceuticals Inc., determining that the generic-drug manufacturer adequately investigated allegations that factory workers ignored computer warnings about the drugs they were making.

Judy Leon, a spokeswoman for the FDA, said the agency was not planning any additional action against the company, a leading generics maker, and that any deviation from standard operating procedures did not result in any compromised drug lots.

The FDA investigation was sparked by a newspaper article published in the Pittsburgh...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.